tiprankstipranks
Trending News
More News >
Waystar Holding Corp. (WAY)
NASDAQ:WAY
US Market

Waystar Holding Corp. (WAY) Earnings Dates, Call Summary & Reports

Compare
235 Followers

Earnings Data

Report Date
May 06, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.39
Last Year’s EPS
0.32
Same Quarter Last Year
Based on 18 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 17, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized substantial positive execution: record bookings, strong top-line growth (Q4 +24% YoY; FY +17% YoY), robust margins (adjusted EBITDA margin ~42–43%), meaningful cash conversion and deleveraging progress, rapid AI adoption and measurable AI outcomes (>$15B denials prevented). Acquisition of Iodine materially expands addressable market and AI/clinical data capabilities with synergies ahead of plan. Key risks discussed include seasonality and deductible timing impacting patient payment revenue, near-term cost step-ups from the acquisition, leverage and cash levels, some one-off tailwinds to retention, and the multi-quarter ramp of large deals. On balance the positives substantially outweigh the challenges.
Company Guidance
Waystar guided 2026 revenue of $1,274,000,000 to $1,294,000,000 (midpoint $1,284,000,000), implying 17% year‑over‑year growth and roughly 10% normalized organic growth (with a similar implied rate for Iodine), and expects sequential revenue growth of 1%–3% through the year (Q3 at the low end due to patient‑payment seasonality); adjusted EBITDA guidance is $530,000,000 to $540,000,000 (midpoint $535,000,000), about 16% year‑over‑year growth and an adjusted EBITDA margin near 42% (gross margin ~68%), which includes ~1% margin uplift from realizing approximately $14,000,000 of acquisition cost synergies in 2026 (over 90% of the committed $15,000,000); management reiterated a long‑term adjusted EBITDA margin target of 40%, expects to run the business at or below ~3.0x net leverage (net leverage was ~3.0x at 12/31) and to delever roughly one turn annually, and assumed healthy patient utilization and that record bookings will ramp over six to eighteen months.
Record Annual Revenue and Guidance
Full-year 2025 revenue reached $1,100,000,000, up 17% year-over-year (organic +13%). Management guided 2026 revenue of $1,274,000,000 to $1,294,000,000 (midpoint $1,284,000,000), implying ~17% year-over-year growth with ~10% normalized organic growth.
Strong Q4 Revenue and Organic Growth
Q4 2025 revenue was $304,000,000, up 24% year-over-year and 12% organically. Both subscription and volume-based revenue contributed to growth.
Margin Expansion and Adjusted EBITDA Growth
Adjusted EBITDA for Q4 was $129,000,000 (margin ~43%), up 29% year-over-year. Full-year adjusted EBITDA was $462,000,000 (42% margin), up 21% year-over-year. 2026 adjusted EBITDA guidance midpoint $535,000,000 (approx. +16% YoY) targeting ~42% margin.
Record Bookings and Large Deal Activity
Company reported a record bookings quarter in Q4, including an elevated count of $1M+ bookings (15–20 each in Q3 and Q4, more than 2x the three-year quarterly average), supporting forward visibility despite multi-quarter ramp timelines.
Iodine Acquisition and Synergy Progress
Completed acquisition of Iodine: contributed $31,000,000 in Q4, added >1,000 hospitals/health systems with ~35% customer overlap. Integration is ahead of plan and management expects to realize >90% of committed $15,000,000 cost synergies in fiscal 2026 (~$14,000,000).
AI Performance and Adoption
Waystar Altitude AI prevented >$15,000,000,000 in denials in 2025, reduced appeal package generation time by 90%, drove double-digit increases in denial overturn rates, and launched agentic capabilities that cut documentation analysis by ~40%. About 50 solutions leverage AI and ~40% of revenue is driven by AI; ~30% of 2025 new bookings were AI-powered.
Strong Retention, NPS and Commercial Metrics
Net revenue retention (NRR) was 112% (last twelve months) with 97% gross revenue retention. Net promoter score exceeded 70. Clients with >$100k LTM revenue increased by 85 in Q4 to 1,391 (+16% YoY), and win rates improved above a historical ~80%.
Cash Flow, Leverage Improvement and Conversion
Unlevered free cash flow was $80,000,000 in Q4 and $365,000,000 for the full year, converting 79% of adjusted EBITDA to unlevered free cash flow. Net leverage was ~3.0x as of Dec 31, down ~0.5x since the Iodine close, with plan to run at or below 3.0x and delever ~1.0x per year.

Waystar Holding Corp. (WAY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

WAY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 2026
2026 (Q1)
0.39 / -
0.32
Feb 17, 2026
2025 (Q4)
0.39 / 0.36
0.2924.14% (+0.07)
Oct 29, 2025
2025 (Q3)
0.35 / 0.37
0.14164.29% (+0.23)
Jul 30, 2025
2025 (Q2)
0.34 / 0.36
0.04800.00% (+0.32)
Apr 30, 2025
2025 (Q1)
0.32 / 0.32
-0.04900.00% (+0.36)
Feb 18, 2025
2024 (Q4)
0.14 / 0.29
-0.086437.21% (+0.38)
Nov 06, 2024
2024 (Q3)
0.11 / 0.14
-0.093250.54% (+0.23)
Aug 07, 2024
2024 (Q2)
-0.03 / 0.04
-0.065161.54% (+0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

WAY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 17, 2026
$22.41$24.31+8.48%
Oct 29, 2025
$39.62$37.06-6.46%
Jul 30, 2025
$35.64$36.98+3.76%
Apr 30, 2025
$37.17$39.46+6.16%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Waystar Holding Corp. (WAY) report earnings?
Waystar Holding Corp. (WAY) is schdueled to report earning on May 06, 2026, After Close (Confirmed).
    What is Waystar Holding Corp. (WAY) earnings time?
    Waystar Holding Corp. (WAY) earnings time is at May 06, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is WAY EPS forecast?
          WAY EPS forecast for the fiscal quarter 2026 (Q1) is 0.39.